How Immunotherapy Is Making an Impact in Liver Cancer December 21, 2018October 31, 2024 Arthur N. Brodsky, PhD
FDA Approves Pembrolizumab Immunotherapy for Advanced Liver Cancer November 9, 2018October 31, 2024 Arthur N. Brodsky, PhD
Checkpoint Immunotherapy Approved for Patients with Stomach, Gastroesophageal, and Liver Cancer September 25, 2017December 14, 2022 Arthur N. Brodsky, PhD